Lassie Achieves Significant Funding Milestone In a significant boost for its growth and development, Lassie , a promising startup in the tech space, has successfully raised $35 million in a Series A funding round. This round was...
Quobly Secures Major Funding for Quantum Leap The French startup Quobly has successfully raised €115 million in a Series A funding round, marking one of Europe's largest investments in quantum computing this year. Led by Bpifrance , SEALSQ...
Gigaton's Ambitious Vision for Heavy Industry Gigaton , a London-based startup formerly known as Carbon Re, has made waves in the industrial sector by securing $26 million in a Series A funding round led by Plural . This latest investment...
IMU Biosciences Secures Major Funding for Immune Analysis In a significant leap for precision medicine , London-based IMU Biosciences has successfully raised over $53 million in an oversubscribed Series A funding round, co-led by IQ...
Gradient Labs Expands Series A Funding Gradient Labs , a London-based startup founded by former team members from Monzo , has successfully expanded its Series A funding to a total of $26 million. This includes an additional $13 million...
Quantum Bridge raised $8 million in a Series A round led by Primo Capital SGR to develop quantum cybersecurity tools.
French startup Mantle8 secured €31 million in Series A funding, bringing its total capital raised to €37 million for natural hydrogen exploration.
Adfin has secured $18 million in Series A funding led by Index Ventures, bringing its total capital raised to more than $30 million since 2024.
French startup OpsMill has raised $14 million in Series A funding led by IRIS to scale its Infrahub infrastructure data management platform.
Ethos secured $22.75 million in Series A funding on Tuesday led by Andreessen Horowitz to expand its alternative recruitment platform.
Blockworks closed a Series A funding extension valuing the New York crypto data platform at $192 million, the company said.
Munich-based biotech firm mbiomics secured 30 million euros in a Series A funding round led by MIG Fonds and Bayern Kapital to push its gut microbiome cancer therapy into Phase 1B clinical trials.